PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.640.06 (1.08%)
5.46 - 5.64
4.95 - 8.28
2.0K / 2.4K (Avg.)
-282.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.70%
Negative revenue growth while VALMT.HE stands at 38.86%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
0.46%
Gross profit growth under 50% of VALMT.HE's 59.29%. Michael Burry would be concerned about a severe competitive disadvantage.
55.92%
EBIT growth below 50% of VALMT.HE's 146.15%. Michael Burry would suspect deeper competitive or cost structure issues.
55.92%
Operating income growth under 50% of VALMT.HE's 146.15%. Michael Burry would be concerned about deeper cost or sales issues.
86.69%
Net income growth at 50-75% of VALMT.HE's 162.50%. Martin Whitman would question fundamental disadvantages in expenses or demand.
66.67%
EPS growth under 50% of VALMT.HE's 180.00%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
66.67%
Diluted EPS growth under 50% of VALMT.HE's 180.00%. Michael Burry would worry about an eroding competitive position or excessive dilution.
12.01%
Share change of 12.01% while VALMT.HE is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
12.01%
Diluted share change of 12.01% while VALMT.HE is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
71.69%
OCF growth under 50% of VALMT.HE's 185.00%. Michael Burry might suspect questionable revenue recognition or rising costs.
-407.87%
Negative FCF growth while VALMT.HE is at 126.67%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-18.90%
Negative 10Y revenue/share CAGR while VALMT.HE stands at 45.60%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-43.53%
Negative 5Y CAGR while VALMT.HE stands at 45.60%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-10.34%
Negative 3Y CAGR while VALMT.HE stands at 45.60%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
353.57%
10Y OCF/share CAGR 1.25-1.5x VALMT.HE's 289.06%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
285.47%
5Y OCF/share CAGR is similar to VALMT.HE's 289.06%. Walter Schloss might see parallel cost profiles or expansions producing comparable cash flow.
256.35%
3Y OCF/share CAGR at 75-90% of VALMT.HE's 289.06%. Bill Ackman would press for improvements in margin or overhead to catch up.
152.33%
Below 50% of VALMT.HE's 1301.27%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
600.00%
Below 50% of VALMT.HE's 1301.27%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-64.97%
Negative 3Y CAGR while VALMT.HE is 1301.27%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
-22.27%
Negative 5Y equity/share growth while VALMT.HE is at 27.75%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
12.10%
Below 50% of VALMT.HE's 27.75%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.47%
Firm’s AR is declining while VALMT.HE shows 24.90%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-8.40%
Inventory is declining while VALMT.HE stands at 4.22%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-4.19%
Negative asset growth while VALMT.HE invests at 5.42%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-3.68%
We have a declining book value while VALMT.HE shows 2.14%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-2.07%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
3.08%
SG&A declining or stable vs. VALMT.HE's 30.77%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.